Please login to the form below

Not currently logged in
Email:
Password:

GLI names VP of scientific and regulatory affairs

Dr Brian Harvey joins from Pfizer

The Global Liver Institute (GLI) has name Dr Brian Harvey as executive vice president of scientific and regulatory affairs, having been a member since its founding in 2014.

In the role, Harvey will support and guide GLI on scientific, medical and regulatory matters, supporting the institute's aim to promote innovation, encourage collaboration between diverse partners and optimise approaches to beat liver diseases.

Founder and president of GLI, Donna Cryer, said: “Brian not only has a wealth of medical knowledge and experience as a practicing physician, but, having worked within both U.S. Food and Drug Administration and at several leading pharmaceutical companies, he brings to GLI extensive industry experience that will help us identify opportunities to transform the field of liver disease.”

Harvey joins from Pfizer, where he most recently served as VP of US regulatory strategy, covering pharma and biologics across all therapy areas. Prior to joining Pfizr, he held the role of VP of US regulatory policy for Sanofi-Aventis.

Harvey has also previously held positions at the FDA, including working as director of the regulator's division of gastroenterology products.

Commenting on his appointment, Harvey said: “I'm proud to join Donna and her team as they apply their new formula for advocacy and collaboration to tackle the complex public health issues surrounding liver disease.

“Liver disease affects over 30 million people in this country alone, and I believe GLI's approach to advocacy can not only raise awareness of liver disease, but rapidly develop and disseminate solutions that can improve the lives of patients and their families.”

22nd June 2015

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...

Infographics